Sector ratings AbbVie Inc.

Equities

Market Closed - Nyse Other stock markets 21:00:03 13/02/2026 GMT			5-day change	1st Jan Change
231.50 ^USD	+1.76%		+3.69%	+1.32%

02-13	China Medical University Hospital Collaborates with Ever Supreme Bio Technology to Develop Exosome Platform	CI
02-12	AbbVie sues US health agency over Botox price controls	RE

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Visibility	Consensus
ABBVIE INC.	409B		AA
ELI LILLY AND COMPANY	929B		A
JOHNSON & JOHNSON	587B		BBB
ROCHE HOLDING AG	375B		AA
ASTRAZENECA PLC	320B		A
NOVARTIS AG	314B		AAA
MERCK & CO., INC.	301B		A
NOVO NORDISK A/S	217B		A
AMGEN INC.	199B		A
GILEAD SCIENCES, INC.	192B		AAA
PFIZER INC.	157B		BBB
VERTEX PHARMACEUTICALS INCORPORATED	125B		AA
BRISTOL-MYERS SQUIBB COMPANY	124B		A
GSK PLC	119B		AA
SANOFI	111B		A
CHUGAI PHARMACEUTICAL CO., LTD.	99.53B		AA
ALLERGAN PLC	63.66B	-	-	-	-	-	-	-
TAKEDA PHARMACEUTICAL COMPANY LIMITED	56.96B		AA
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	55.99B		AA
BAYER AG	53.5B		AA
Average	240.46B		AA
Weighted average by Cap.			AA